You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inactivated-adjuvanted SARS-CoV-2 virus vaccine

Showing 9951 - 9975 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Adenomatous Polyposis Trial in Bologna (Eicosapentaenoic acid free fatty acid (EPA-FFA), Placebo)

Recruiting
  • Familial Adenomatous Polyposis
  • Eicosapentaenoic acid free fatty acid (EPA-FFA)
  • Placebo
  • Bologna, Italy
    University of Bologna and St.Orsola-Malpighi Hospital
Oct 26, 2022

Heart Failure With Preserved Ejection Fraction, Obesity Trial in Oxford (Diet intervention)

Recruiting
  • Heart Failure With Preserved Ejection Fraction
  • Obesity
  • Diet intervention
  • Oxford, United Kingdom
    Oxford Centre for Clinical Magnetic Resonance Research, John Rad
May 23, 2023

Cognitive Function and Brain Magnetic Resonance in Maintenance

Recruiting
  • Maintenance Hemodialysis
  • Chinese version of the Montreal Cognitive Assessment Scale (MoCA) and brain magnetic resonance high resolution structural imaging
  • Beijing, Beijing, China
  • +1 more
Jul 24, 2023

Hemophilia A, Hemophilia B Trial (SerpinPC)

Not yet recruiting
  • Hemophilia A
  • Hemophilia B
  • (no location specified)
Mar 16, 2023

Dental Phobia, Dental Anxiety, Anesthesia, Local Trial in Baghdad (dental syringe ( NumBee), Traditional dental syringe)

Completed
  • Dental Phobia
  • +3 more
  • dental syringe ( NumBee)
  • Traditional dental syringe
  • Baghdad, KHARkh, Iraq
    University of Baghdad
Jun 2, 2023

Severe Hypertriglyceridemia Trial in Worldwide (ARO-APOC3, Placebo)

Active, not recruiting
  • Severe Hypertriglyceridemia
  • Beverly Hills, California
  • +72 more
Nov 29, 2022

Malaria Surveillance in Rakai, Uganda

Completed
  • Malaria
    • Rakai, Uganda
      Rakai Health Sciences Program
    Jan 21, 2023

    Stage III NSCLC, Surgery Trial in Guangzhou (Lorlatinib)

    Not yet recruiting
    • Stage III NSCLC
    • Surgery
    • Guangzhou, Guangdong, China
      Guangdong Provincial People's Hospital
    Feb 21, 2023

    Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin Trial in Worldwide (JNJ-67856633, Ibrutinib)

    Active, not recruiting
    • Leukemia, Lymphocytic, Chronic, B-Cell
    • Lymphoma, Non-Hodgkin
    • Copenhagen, Denmark
    • +9 more
    Jan 27, 2023

    Fat Necrosis, Muscle Stimulation Trial in Billerica, New York (Accufit)

    Completed
    • Fat Necrosis
    • Muscle Stimulation
    • Accufit
    • Billerica, Massachusetts
    • +1 more
    Nov 22, 2023

    Depression Trial run by the NIMH (11C-MCI, 11CPS13)

    Recruiting
    • Depression
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Feb 2, 2023

    Breast Cancer Trial in Shanghai (KN026)

    Recruiting
    • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Cancer Hospital
    Jun 16, 2022

    Bariatric Surgery Candidate Trial in Alexandria (protective lung strategy with recruitment manoeuvre (RM) - steady PEEP,

    Completed
    • Bariatric Surgery Candidate
    • protective lung strategy with recruitment manoeuvre (RM) - steady PEEP
    • protective lung strategy with recruitment manoeuvre (RM) - decreasing PEEP
    • Alexandria, Egypt
      Alexandria University Faculty of Medicin
    Jul 18, 2023

    TES of Chloroquine for Pv in the Philippines in 2016

    Completed
    • Malaria
    • +2 more
    • (no location specified)
    Jul 20, 2023

    Locally Advanced Solid Tumor, Metastatic Solid Tumor Trial in Worldwide (NVL-520)

    Recruiting
    • Locally Advanced Solid Tumor
    • Metastatic Solid Tumor
    • Orange, California
    • +18 more
    Oct 6, 2022

    Aromatherapy by Olfaction of Essential Oils in Association With

    Not yet recruiting
    • Cancer
    • hypnosis
    • Hypnosis with aromatherapy
    • Créteil, France
      Centre Hospitalier Intercommunal de Créteil
    Feb 3, 2023

    Healthy Subjects Trial in Daytona Beach (Placebo, PB 718)

    Completed
    • Healthy Subjects
    • Placebo
    • PB 718
    • Daytona Beach, Florida
      Covance Clinical Research Unit Inc.
    Sep 27, 2022

    COVID-19 Acute Respiratory Distress Syndrome, Respiratory Distress Syndrome Trial in Liberty (EV-Pure™ and WJ-Pure™, Placebo)

    Recruiting
    • COVID-19 Acute Respiratory Distress Syndrome
    • Respiratory Distress Syndrome
    • EV-Pure™ and WJ-Pure™
    • Placebo
    • Liberty, Missouri
      Kit Bartalos
    Oct 11, 2022

    Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement Trial (TAS-120)

    Not yet recruiting
    • Advanced Cholangiocarcinoma
    • +2 more
    • (no location specified)
    Feb 3, 2023

    Sarcoma,Soft Tissue, Pulmonary Metastasis Trial in United States (Liposomal Annamycin (L-Annamycin))

    Recruiting
    • Sarcoma,Soft Tissue
    • Pulmonary Metastasis
    • Liposomal Annamycin (L-Annamycin)
    • Santa Monica, California
    • +4 more
    Aug 16, 2022

    Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening

    Not yet recruiting
    • Esophageal Cancer
    • Transnasal Esophagoscopy (TNE)
    • Chicago, Illinois
      Mile Square Health Center-University of Illinois Hospital
    Jul 27, 2022

    STEMI Trial in Cairo (Dapagliflozin)

    Recruiting
    • STEMI
    • Cairo, Egypt
      Helwan University
    Jul 16, 2023

    Bone Conduction Deafness, Quality of Life, Hearing Loss, Mixed Trial in Madrid (Fitting of the audioprocessor with the auditory

    Recruiting
    • Bone Conduction Deafness
    • +2 more
    • Fitting of the audioprocessor with the auditory implant BCI602
    • Madrid, Spain
      Hospital Universitario La Paz
    Sep 9, 2023

    Systemic Lupus Erythematosus, Lupus Nephritis Trial in Nanjing (Human umbilical cord mesenchymal stem cells, Interleukin-2)

    Recruiting
    • Systemic Lupus Erythematosus
    • Lupus Nephritis
    • Nanjing, Jiangsu, China
      The Affiliated Nanjing Drum Tower Hospital of Nanjing University
    Nov 20, 2022

    Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)

    Not yet recruiting
    • Thyroid Cancer
    • 20 mg Famitinib & 1200 mg Adebrelimab
    • (no location specified)
    Nov 26, 2023